Sorrento Therapeutics Inc (NASDAQ:SRNE)

10.52
Delayed Data
As of Apr 24
 -0.15 / -1.41%
Today’s Change
3.10
Today|||52-Week Range
14.30
+4.47%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues529.2K583.8K460.1K3.8M
 
 
 
 
 
Cost of Goods Sold2.4M--4.4K1.2M
 
 
 
 
Depreciation And Amortization159.2K293.3K1.3M3.2M
 
 
 
 
 
 
Operating ExpensesGross Income-2.0M---834.7K-563.0K
 
 
 
 
General Expenses1.2M5.1M14.8M34.0M
 
 
 
 
 
Research And Development--3.8M9.0M24.0M
 
 
 
 
Total Operating Expenses3.8M5.4M16.1M38.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.2M-4.9M-15.7M-34.5M
 
 
 
 
 
Extraordinary Charge0.000.00-6.0M-209.0K
 
 
 
Interest Expense On Debt0.000.00253.2K1.6M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.2M-4.8M-21.9M-36.4M
 
 
 
 
 
Income Taxes0.000.000.00-1.7M
 
 
Net Income-3.2M-4.8M-21.9M-34.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.9M11.4M15.0M26.7M
 
 
 
 
 
Shares To Calculate EPS Diluted9.9M11.4M15.0M26.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.25-$0.50-$1.46-$1.30
 
 
 
 
 
EPS Diluted-$0.25-$0.50-$1.46-$1.30
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account